Molecular subtypes and precision treatment of triple-negative breast cancer

por Zhao, Shen, Zuo, Wen-Jia, Shao, Zhi-Ming, Jiang, Yi-Zhou
Publicado 2020

Immediate Postmastectomy Breast Reconstruction Showed Limited Advantage in Patient Survival after Stratifying by Family Income

por Jiang, Yi-Zhou, Liu, Yi-Rong, Yu, Ke-Da, Zuo, Wen-Jia, Shao, Zhi-Ming
Publicado 2013

PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis

por Liu, Yi-Rong, Jiang, Yi-Zhou, Zuo, Wen-Jia, Yu, Ke-Da, Shao, Zhi-Ming
Publicado 2014

Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study

por Liu, Xi-Yu, Jiang, Yi-Zhou, Liu, Yi-Rong, Zuo, Wen-Jia, Shao, Zhi-Ming
Publicado 2015

Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement

por Liu, Yin, He, Min, Zuo, Wen-Jia, Hao, Shuang, Wang, Zhong-Hua, Shao, Zhi-Ming
Publicado 2021

Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant

por He, Min, Li, Jun‐Jie, Zuo, Wen‐Jia, Ji, Lei, Jiang, Yi‐Zhou, Hu, Xi‐Chun, Wang, Zhong‐Hua, Shao, Zhi‐Ming
Publicado 2019

An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy

por Ni, Xiao-Jian, Zhang, Xiao-Lan, Ou-Yang, Qian-Wen, Qian, Guo-Wei, Wang, Lei, Chen, Sheng, Jiang, Yi-Zhou, Zuo, Wen-Jia, Wu, Jiong, Hu, Xin, Shao, Zhi-Ming
Publicado 2014

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

por Jiang, Yi-Zhou, Liu, Yin, Xiao, Yi, Hu, Xin, Jiang, Lin, Zuo, Wen-Jia, Ma, Ding, Ding, Jiahan, Zhu, Xiaoyu, Zou, Jianjun, Verschraegen, Claire, Stover, Daniel G., Kaklamani, Virginia, Wang, Zhong-Hua, Shao, Zhi-Ming
Publicado 2020

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

por Liu, Yi-Rong, Jiang, Yi-Zhou, Xu, Xiao-En, Yu, Ke-Da, Jin, Xi, Hu, Xin, Zuo, Wen-Jia, Hao, Shuang, Wu, Jiong, Liu, Guang-Yu, Di, Gen-Hong, Li, Da-Qiang, He, Xiang-Huo, Hu, Wei-Guo, Shao, Zhi-Ming
Publicado 2016

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

por Chen, Li, Yang, Liu, Yao, Ling, Kuang, Xia-Ying, Zuo, Wen-Jia, Li, Shan, Qiao, Feng, Liu, Yi-Rong, Cao, Zhi-Gang, Zhou, Shu-Ling, Zhou, Xiao-Yan, Yang, Wen-Tao, Shi, Jin-Xiu, Huang, Wei, Hu, Xin, Shao, Zhi-Ming
Publicado 2018

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial

por Liu, Yin, Zhu, Xiu-Zhi, Xiao, Yi, Wu, Song-Yang, Zuo, Wen-Jia, Yu, Qiang, Cao, A-Yong, Li, Jun-Jie, Yu, Ke-Da, Liu, Guang-Yu, Wu, Jiong, Sun, Tao, Cui, Jiu-Wei, Lv, Zheng, Li, Hui-Ping, Zhu, Xiao-Yu, Jiang, Yi-Zhou, Wang, Zhong-Hua, Shao, Zhi-Ming
Publicado 2023

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

por Jin, Xi, Xu, Xiao-En, Jiang, Yi-Zhou, Liu, Yi-Rong, Sun, Wei, Guo, Ya-Jie, Ren, Yi-Xing, Zuo, Wen-Jia, Hu, Xin, Huang, Sheng-Lin, Shen, Hong-Jie, Lan, Fei, He, Yun-Fei, Hu, Guo-Hong, Di, Gen-Hong, He, Xiang-Huo, Li, Da-Qiang, Liu, Suling, Yu, Ke-Da, Shao, Zhi-Ming
Publicado 2019